Navigation Links
Important Data Presented on Independent Predictors of Mortality in Patients With Idiopathic Pulmonary Fibrosis
Date:5/17/2009

InterMune, said, "We view the results of this study as clinically important and supportive of the results from our Phase 3 CAPACITY program, in which the primary endpoint was change in percent predicted FVC."

The analysis in the du Bois study employed longitudinal data from two large prospective clinical trials in patients with IPF. A total of 1,099 well-characterized patients who participated in the GIPF-001 and GIPF-007 (INSPIRE) trials were included in the analysis. In addition to a comprehensive multivariate model that considered all potential predictors of one-year mortality, researchers developed a practical model based on widely available and reliable measures, including FVC change, that can be used in the clinical setting to assess the near-term risk of death in patients with IPF. Dr. du Bois added, "What the practicing clinician needs is an index that is simple to apply in the office and that predicts likely outcome for an individual patient over the short term. To be able to add this information into the risk/benefit equation for that individual patient will allow a more informed management strategy to be defined. This study has provided such an index."

About the CAPACITY Program

InterMune has reported the results of two concurrent, randomized, double-blind, placebo controlled, Phase 3 trials, known as CAPACITY 1 and CAPACITY 2, evaluating the safety and efficacy of pirfenidone for the treatment of patients with IPF. In CAPACITY 2, treatment with pirfenidone resulted in a statistically and clinically significant reduction in the loss of forced vital capacity (FVC) and increase in progression-free survival time. In CAPACITY 1, the difference between pirfenidone and placebo in FVC change at week 72 was not statistically significant; however, the overall results were consistent with those of CAPACITY 2, suggesting a treatment benefit. Treatment with pirfenidone was safe and generally well tolerated;
'/>"/>

SOURCE InterMune, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine news :

1. CMSA Delivers Important Message to Congress: Case Management Services Improve Patient Care and Should Be Key Strategy in Health Care Reform Initiatives
2. What Motivates Physicians to Succeed? Money Isn't Most Important
3. Major statin study reveals several important findings for reducing prostate cancer and disease
4. Leapfrog Group Hospital Survey Finds Majority of Hospitals Fail to Meet Important Quality Standards
5. New Research Shows Tree Nuts May Play an Important Role in the Health of People With Diabetes
6. UT Southwestern researchers reveal how the brain processes important information
7. Nu Skin Charitable Promotion Reaches Important Milestone: 100,000 Trees Donated to African Nation of Malawi
8. AUDIO from Medialink and Mens Health Network: Important Decision Regarding Prostate Cancer
9. Penn researchers identify new protein important in breast cancer genes role in DNA repair
10. Important new model shows how proteins find the right DNA sequences
11. Why Blood and Bone Marrow Donors Are So Important: Extreme Makeover: Home Edition Profiles Blood Drive Honoree Lizzie Bell
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... , , TUESDAY, May 21 (HealthDay News) -- The overall ... in 10 people either overweight or obese and large ... or not exercising, a new government report shows. , ... Control and Prevention, the report found Americans continuing to ... to soaring rates of heart disease, diabetes and other ...
(Date:5/22/2013)... Teams who focus on productivity, process, quality, ... Do-Done StepTracker whiteboard as a rallying point for project ... display the current status of our company-wide lean initiatives ... is listed down the side and the milestones are ... squares are filled with yellow circles. Turning the magnets ...
(Date:5/22/2013)... Paris, France: Results from a large observational ... whether bivalirudin is superior to heparin in ... 30-day mortality in patients with non-ST segment ... coronary intervention (PCI)., European and US NSTE-ACS ... alternative to unfractionated heparin plus GP IIb/IIIa ...
(Date:5/22/2013)... 22, 2013 The PreDiabetes Center ... in the Greater Philadelphia Tour de Cure, a premier cycling ... are passionate about stopping the spread of diabetes , ... , The Tour de Cure will take place Saturday, ... Road in Ambler, 30 minutes outside of Philadelphia, between the ...
(Date:5/22/2013)... New York City, New York (PRWEB) May 22, 2013 ... Black American: Causes, Culture, Consequences, and Cost ” article published ... on obesity is fully justified. The Centers for Disease ... of U.S. adults aged 20 and over are overweight, 35.7% ... alarming facts are highlighted in this investigative article. In particular, ...
Breaking Medicine News(10 mins):Health News:Americans Still Making Unhealthy Choices: CDC 2Health News:Americans Still Making Unhealthy Choices: CDC 3Health News:Project Managers Organize Manufacturing Projects and Training with the New Steptracker Project Status Magnetic Whiteboards 2Health News:Registry questions superiority of bivalirudin over heparin 2Health News:PreDiabetes Centers to Appear at the Philadelphia Tour de Cure 2Health News:PreDiabetes Centers to Appear at the Philadelphia Tour de Cure 3Health News:Black American Obesity Examined In The Latest FinancesOnline.com Article 2Health News:Black American Obesity Examined In The Latest FinancesOnline.com Article 3
... Dr. Eric Olson, chairman of molecular biology at UT ... France,s prestigious Lefoulon-Delalande Foundation Grand Prize for his work ... The prize has an international reputation as the ... about $664,000 (500,000 euros) will be presented June 10 ...
... , LOUISVILLE, Colo., June 4 /PRNewswire/ -- ... 13 GHXcellence Awards for achievements in improving supply chain performance. ... a recognition ceremony in Nashville at the 9th Annual GHX ... focused on both the buy and sell side of the ...
... The Minneapolis-St. Paul office of Weber Shandwick has been ... the organization,s largest annual awareness campaign. The "Be The ... to reach a diverse audience of current and potential ... with leukemia and other life-threatening diseases, a marrow transplant ...
... to Reduce Administrative Costs in Healthcare and Streamlines Processes ... N.J., June 4 MD On-Line Inc ... core focus of converting paper submitting providers to electronic ... Corp. (MCC) of Bristol, CT. Both are EHNAC-accredited ...
... nursing homes with one in four residents carrying the bacteria, a ... Its authors say that the findings, which have been ... highlight the need for infection control strategies to be given a ... be the largest of its kind studying MRSA in private nursing ...
... Fitness and Nutrition Program from Fitness Expert Monique Hollowell ... often feel their bodies will never be the same ... a fit pregnancy, less painful birth and quick recovery ... and personal trainer, Monique Hollowell has created a fitness ...
Cached Medicine News:Health News:UT Southwestern's Olson wins prestigious French award for heart research 2Health News:GHXcellence Awards Honor Healthcare Providers and Suppliers for Achievements in Supply Chain Performance 2Health News:GHXcellence Awards Honor Healthcare Providers and Suppliers for Achievements in Supply Chain Performance 3Health News:Weber Shandwick Chosen By National Marrow Donor Program(R) To Head Awareness Campaign 2Health News:Weber Shandwick Chosen By National Marrow Donor Program(R) To Head Awareness Campaign 3Health News:MD On-Line Inc. Acquires Medical Claim Corp. 2Health News:1 in 4 nursing home residents carry MRSA 2Health News:Keys to a Fit Pregnancy and Losing the Baby Weight 2Health News:Keys to a Fit Pregnancy and Losing the Baby Weight 3
(Date:5/22/2013)... YORK , May 22, 2013 While ... their teens, friends to drink at home under adult ... about drinking, the truth is that there are serious ... Partnership at Drugfree.org and The Treatment Research ... new, interactive web resource for parents and caregivers to ...
(Date:5/22/2013)... 2013 PRNewswire – iBio, Inc. (NYSE ... vaccine candidate for the newly emerged H7N9 influenza ... the iBioLaunch™ platform. This validation milestone was achieved ... sequence information to purification of recombinant protein. ... The iBioLaunch platform eliminates the need to ...
(Date:5/22/2013)... 22, 2013 WomanCare Global recently launched ... an extensive training initiative attended by 90 health ... ) (Logo: http://photos.prnewswire.com/prnh/20101018/DC83896LOGO ) Simplant, ... highly effective subdermal implant composed of two thin, ... (a synthetic form of the hormone progestin). These ...
Breaking Medicine Technology:Myths Debunked: Underage Drinking of Alcohol at Home Leads to Real Consequences for Both Parents and Teens 2Myths Debunked: Underage Drinking of Alcohol at Home Leads to Real Consequences for Both Parents and Teens 3Myths Debunked: Underage Drinking of Alcohol at Home Leads to Real Consequences for Both Parents and Teens 4Myths Debunked: Underage Drinking of Alcohol at Home Leads to Real Consequences for Both Parents and Teens 5Myths Debunked: Underage Drinking of Alcohol at Home Leads to Real Consequences for Both Parents and Teens 6Myths Debunked: Underage Drinking of Alcohol at Home Leads to Real Consequences for Both Parents and Teens 7iBio Technology Produces Vaccine Candidate for Recently Emerged H7N9 Influenza 2WomanCare Global launches Simplant, Long-acting Reversible Contraception, in Chile 2
... SAN DIEGO, Feb. 3, 2011 Neurocrine Biosciences, Inc. (Nasdaq: ... report its fourth quarter and year-end 2010 financial results after ... will then host a live conference call and webcast to ... afternoon, February 10, 2011 at 5:00 p.m. Eastern Time (2:00 ...
... 2011 SkinMedica, Inc., the fastest-growing professional skin ... that it is introducing a new, fast-acting anti-redness ... in over two decades.  It is the first ... visible redness.     (Photo: ...
Cached Medicine Technology:SkinMedica Launches Redness Relief CalmPlex™ 2SkinMedica Launches Redness Relief CalmPlex™ 3
EnTrust family of ICDs provides a suite of features for total AT/AF co-morbidity management, including diagnostics to detect when your patient develops AT/AF, and both termination and intervention th...
... Medical is the world leader in ... used worldwide for permanent pacemaker and ... and port implantation, and for temporary ... St. Jude Medical Peel-Away introducers includes ...
... Stent System combines low-profile, high radial force, and ... wire compatible stent system provides 6F sheath / ... - 10.0 mm). Now, with longer stents available, ... stent lengths (28, 38, 56, 80 and 100 ...
... transseptal left heart catheterization occurs when the ... a sheath with an alternate curve while ... an exchange has required a repeat septal ... has overcome this problem with the unique ...
Medicine Products: